Cargando…
TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
The Tripartite Motif Containing 44 (TRIM44) is highly expressed in a variety of tumours. However, the TRIM44's role in endometrial carcinoma (EC) progression remains unknown. To investigate the TRIM44's role in the development and metastasis of EC, we detected TRIM44 expression in EC cell...
Autores principales: | Song, Yurong, Zhou, Guiju, Song, Enxue, Zhan, Lei, Wang, Qingyuan, Song, Hui, Xia, Jingxian, Cong, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663230/ https://www.ncbi.nlm.nih.gov/pubmed/36387361 http://dx.doi.org/10.1155/2022/6235771 |
Ejemplares similares
-
Retracted: TRIM44 Promotes Endometrial Carcinoma Progression by Activating the FRS2 Signalling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway
por: Xiong, Dian, et al.
Publicado: (2018) -
Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling
por: Peng, Rui, et al.
Publicado: (2018) -
TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4
por: Wei, Chuan-Yuan, et al.
Publicado: (2019) -
Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway
por: Meng, Fanling, et al.
Publicado: (2022)